Latest Breaking News On - Aiolos bio - Page 1 : comparemela.com

GSK's experimental drug shows promise in reducing severe asthma attacks

GSK s experimental drug met its primary goal of reducing asthma attacks in a late-stage trial, marking a bright spot for a treatment that the British drugmaker expects to make peak annual sales of 3.

Stevenage
Hertfordshire
United-kingdom
Bengaluru
Karnataka
India
British
Nivedita-bhattacharjee
Eva-mathews
Aiolos-bio
Tony-wood
Reuters

GSK's Potential Blockbuster Asthma Drug Shows Promise in Latest Trial -- 2nd Update

By Najat Kantouar and Helena Smolak GSK s experimental drug for asthma met its goals in the latest trial, moving a treatment with potential annual peak sales of more than 3 billion pounds .

United-kingdom
British
Helena-smolak
Emma-walmsley
Najat-kantouar
Aiolos-bio
Pfizer
Chief-executive-emma-walmsley
Dow-jones

Experimental Drug Significantly Reduces Asthma Attacks

Experimental Drug Significantly Reduces Asthma Attacks
newsmax.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsmax.com Daily Mail and Mail on Sunday newspapers.

Stevenage
Hertfordshire
United-kingdom
British
Aiolos-bio
Tony-wood

Health: GSK's experimental drug shows promise in reducing severe asthma attacks

Health: GSK's experimental drug shows promise in reducing severe asthma attacks
gdnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gdnonline.com Daily Mail and Mail on Sunday newspapers.

Stevenage
Hertfordshire
United-kingdom
British
Aiolos-bio
Tony-wood

GSK's experimental drug reduces asthma attacks in late-stage trial

Tha pharma giant, which is building out its respiratory portfolio, shared results of a late-stage clinical trial for its long-acting asthma medication

London
City-of
United-kingdom
United-states
Aiolos-bio
Wall-street-journal